Journal article 136 views
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae
Lucas Tselepis 
,
Gareth W. Langley ,
Ali F. Aboklaish,
Emma Widlake,
Dana E. Jackson,
Timothy R. Walsh,
Chris J. Schofield,
Jürgen Brem,
Jon Tyrrell
,
Gareth W. Langley ,
Ali F. Aboklaish,
Emma Widlake,
Dana E. Jackson,
Timothy R. Walsh,
Chris J. Schofield,
Jürgen Brem,
Jon Tyrrell
International Journal of Antimicrobial Agents, Volume: 56, Issue: 1, Start page: 105925
Swansea University Author:
Jon Tyrrell
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/j.ijantimicag.2020.105925
Abstract
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae
| Published in: | International Journal of Antimicrobial Agents |
|---|---|
| ISSN: | 0924-8579 |
| Published: |
Elsevier BV
2020
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa70431 |
| Item Description: |
Short Communication |
|---|---|
| College: |
Faculty of Medicine, Health and Life Sciences |
| Funders: |
GWL, JB and CJS thank Wellcome Trust, the Medical Research Council, the Biotechnology and Biological Research Council (BB/S50676X/1), the Innovative Medicines Initiative (European Lead Factory and ENABLE components), for funding work on antibiotics, MBL fold enzymes and β-lactamase inhibitors. JMT, AA and EW would also like to thank ENABLE for funding antimicrobial-related research. |
| Issue: |
1 |
| Start Page: |
105925 |